This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
[P3–018]: A SUMMARY OF BASELINE EFFICACY CHARACTERISTICS FROM THE MINDSET STUDY: A GLOBAL PHASE 3 STUDY OF INTEPIRDINE (RVT‐101) IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER's DISEASE. (1st July 2017)
Record Type:
Journal Article
Title:
[P3–018]: A SUMMARY OF BASELINE EFFICACY CHARACTERISTICS FROM THE MINDSET STUDY: A GLOBAL PHASE 3 STUDY OF INTEPIRDINE (RVT‐101) IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER's DISEASE. (1st July 2017)
Main Title:
[P3–018]: A SUMMARY OF BASELINE EFFICACY CHARACTERISTICS FROM THE MINDSET STUDY: A GLOBAL PHASE 3 STUDY OF INTEPIRDINE (RVT‐101) IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER's DISEASE